Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice.
The experiments reported here indicate that nitric oxide may play an important role in vivo in chemically-induced diabetes mellitus in mice. CBA mice treated with repeated low doses of streptozocin developed sustained hyperglycemia. This was significantly reduced by injections of L-NG-monomethyl-arginine (L-NMMA), a specific inhibitor of the synthesis of nitric oxide, but not affected by the inactive enantiomer, D-NMMA. Histologically the pancreata of animals treated with streptozocin and injected with L-NMMA showed little or no cellular infiltration and significantly lower degrees of islet cell destruction compared to mice treated with streptozocin alone, suggesting that nitric oxide may also be involved in the development of insulitis.
Lukic
M L
ML
Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Yugoslavia.
Stosic-Grujicic
S
S
Ostojic
N
N
Chan
W L
WL
Liew
F Y
FY
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000473:pathology / Q000503:physiopathology*; D007515:Islets of Langerhans / Q000187:drug effects / Q000473:pathology*; D007536:Isomerism; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009336:Necrosis; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013311:Streptozocin / Q000633:toxicity*; D019323:omega-N-Methylarginine
D001786:Blood Glucose; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D013311:Streptozocin; D001120:Arginine